These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 24587675)

  • 1. Stereotactic body radiotherapy for oligo-recurrence within the nodal area from colorectal cancer.
    Seo YS; Kim MS; Yoo HJ; Jang WI
    World J Gastroenterol; 2014 Feb; 20(8):2005-13. PubMed ID: 24587675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Additional chemotherapy improved local control and overall survival after stereotactic body radiation therapy for patients with oligo-recurrence.
    Nakamura M; Hashimoto N; Mayahara H; Uezono H; Harada A; Nishikawa R; Matsuo Y; Kawaguchi H; Nishimura H
    Radiat Oncol; 2018 Apr; 13(1):75. PubMed ID: 29688858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival and prognostic factors in 321 patients treated with stereotactic body radiotherapy for oligo-metastases.
    Fode MM; Høyer M
    Radiother Oncol; 2015 Feb; 114(2):155-60. PubMed ID: 25583567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of stereotactic body radiotherapy for oligometastasis from colorectal cancer.
    Takeda A; Sanuki N; Kunieda E
    World J Gastroenterol; 2014 Apr; 20(15):4220-9. PubMed ID: 24764660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotactic body radiotherapy for lung metastases as oligo-recurrence: a single institutional study.
    Aoki M; Hatayama Y; Kawaguchi H; Hirose K; Sato M; Akimoto H; Miura H; Ono S; Takai Y
    J Radiat Res; 2016 Jan; 57(1):55-61. PubMed ID: 26494115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligo-recurrence predicts favorable prognosis of brain-only oligometastases in patients with non-small cell lung cancer treated with stereotactic radiosurgery or stereotactic radiotherapy: a multi-institutional study of 61 subjects.
    Niibe Y; Nishimura T; Inoue T; Karasawa K; Shioyama Y; Jingu K; Shirato H
    BMC Cancer; 2016 Aug; 16(1):659. PubMed ID: 27542716
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An analysis of a large multi-institutional database reveals important associations between treatment parameters and clinical outcomes for stereotactic body radiotherapy (SBRT) of oligometastatic colorectal cancer.
    Sheikh S; Chen H; Sahgal A; Poon I; Erler D; Badellino S; Dagan R; Foote MC; Louie AV; Redmond KJ; Ricardi U; Biswas T
    Radiother Oncol; 2022 Feb; 167():187-194. PubMed ID: 34952002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recursive partitioning model-based analysis for survival of colorectal cancer patients with lung and liver oligometastases treated with stereotactic body radiation therapy.
    Franzese C; Comito T; Franceschini D; Loi M; Clerici E; Navarria P; De Rose F; Di Brina L; Mancosu P; Reggiori G; Tomatis S; Scorsetti M
    J Cancer Res Clin Oncol; 2020 May; 146(5):1227-1234. PubMed ID: 32056005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Local ablative radiotherapy of oligometastatic colorectal cancer].
    Petersen C; Gauer T
    Radiologe; 2017 Feb; 57(2):105-110. PubMed ID: 28054139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic Radiotherapy for Pulmonary Oligometastases From Colorectal Cancer: A Systematic Review and Meta-Analysis.
    Jingu K; Matsushita H; Yamamoto T; Umezawa R; Ishikawa Y; Takahashi N; Katagiri Y; Takeda K; Kadoya N
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818794936. PubMed ID: 30145943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stereotactic Radiotherapy for Oligometastases in Lymph Nodes-A Review.
    Matsushita H; Jingu K; Umezawa R; Yamamoto T; Ishikawa Y; Takahashi N; Katagiri Y; Kadoya N
    Technol Cancer Res Treat; 2018 Jan; 17():1533033818803597. PubMed ID: 30352542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nodal recurrence after stereotactic body radiotherapy for early stage non-small cell lung cancer: Incidence and proposed risk factors.
    Wink KCJ; van Baardwijk A; Troost EGC; De Ruysscher D
    Cancer Treat Rev; 2017 May; 56():8-15. PubMed ID: 28437679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of local control on overall survival after stereotactic body radiotherapy for liver and lung metastases from colorectal cancer: a combined analysis of 388 patients with 500 metastases.
    Klement RJ; Abbasi-Senger N; Adebahr S; Alheid H; Allgaeuer M; Becker G; Blanck O; Boda-Heggemann J; Brunner T; Duma M; Eble MJ; Ernst I; Gerum S; Habermehl D; Hass P; Henkenberens C; Hildebrandt G; Imhoff D; Kahl H; Klass ND; Krempien R; Lewitzki V; Lohaus F; Ostheimer C; Papachristofilou A; Petersen C; Rieber J; Schneider T; Schrade E; Semrau R; Wachter S; Wittig A; Guckenberger M; Andratschke N
    BMC Cancer; 2019 Feb; 19(1):173. PubMed ID: 30808323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic Body Radiotherapy Results for Pulmonary Oligometastases: A Two-Institution Collaborative Investigation.
    Niibe Y; Yamashita H; Sekiguchi K; Takahashi W; Shiraishi K; Okuma K; Terahara A; Kawamori J; Nakagawa K
    Anticancer Res; 2015 Sep; 35(9):4903-8. PubMed ID: 26254386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidental mediastinal dose does not explain low mediastinal node recurrence rates in patients with early-stage NSCLC treated with stereotactic body radiotherapy.
    Rwigema JC; Chen AM; Wang PC; Lee JM; Garon E; Lee P
    Clin Lung Cancer; 2014 Jul; 15(4):287-93. PubMed ID: 24594401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lung stereotactic radiotherapy for oligometastases: comparison of oligo-recurrence and sync-oligometastases.
    Yamashita H; Niibe Y; Yamamoto T; Katsui K; Jingu K; Kanazawa S; Terahara A; Nakagawa K
    Jpn J Clin Oncol; 2016 Jul; 46(7):687-91. PubMed ID: 27162324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the role of Stereotactic Body Radiation Therapy in a large cohort of patients with lymph node oligometastases: Does it affect systemic treatment's intensification?
    Franzese C; Badalamenti M; Comito T; Franceschini D; Clerici E; Navarria P; Loi M; D'agostino G; Baldaccini D; Chiola I; Reggiori G; Mancosu P; Tomatis S; Scorsetti M
    Radiother Oncol; 2020 Sep; 150():184-190. PubMed ID: 32593644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single-institution study of stereotactic body radiotherapy for patients with unresectable visceral pulmonary or hepatic oligometastases.
    Fumagalli I; Bibault JE; Dewas S; Kramar A; Mirabel X; Prevost B; Lacornerie T; Jerraya H; Lartigau E
    Radiat Oncol; 2012 Sep; 7():164. PubMed ID: 23014094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary Oligometastases Treated by Stereotactic Body Radiation Therapy: A Nationwide Survey of 1,378 Patients.
    Niibe Y; Yamamoto T; Onishi H; Yamashita H; Katsui K; Matsumoto Y; Oh RJ; Aoki M; Shintani T; Yamada K; Kobayashi M; Ozaki M; Manabe Y; Yahara K; Nishikawa A; Kakuhara H; Yamamoto K; Inoue T; Takada YU; Nagata K; Suzuki O; Terahara A; Jingu K
    Anticancer Res; 2020 Jan; 40(1):393-399. PubMed ID: 31892592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
    Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
    Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.